Shawn E. Kotermanski, Ph.D. - Publications
Institution:
University of Pittsburgh, Pittsburgh, PA, United StatesYear | Citation | Score | |||
---|---|---|---|---|---|
2019 | Jackson TC, Janesko-Feldman K, Carlson SW, Kotermanski SE, Kochanek PM. Robust RBM3 and β-klotho expression in developing neurons in the human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19878889. PMID 31566073 DOI: 10.1177/0271678X19878889 | 0.315 | |||
2017 | Jackson EK, Kotermanski SE, Menshikova EV, Dubey RK, Jackson TC, Kochanek PM. Adenosine Production by Brain Cells. Journal of Neurochemistry. PMID 28294336 DOI: 10.1111/Jnc.14018 | 0.351 | |||
2013 | Kotermanski SE, Johnson JW, Thiels E. Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacology, Biochemistry, and Behavior. 109: 67-76. PMID 23665480 DOI: 10.1016/J.Pbb.2013.05.005 | 0.491 | |||
2009 | Kotermanski SE, Wood JT, Johnson JW. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping. The Journal of Physiology. 587: 4589-604. PMID 19687120 DOI: 10.1113/Jphysiol.2009.176297 | 0.533 | |||
2009 | Kotermanski SE, Johnson JW. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2774-9. PMID 19261873 DOI: 10.1523/Jneurosci.3703-08.2009 | 0.533 | |||
2006 | Johnson JW, Kotermanski SE. Mechanism of action of memantine. Current Opinion in Pharmacology. 6: 61-7. PMID 16368266 DOI: 10.1016/J.Coph.2005.09.007 | 0.56 | |||
Show low-probability matches. |